ArticleClinical ophthalmology (Auckland, N.Z.)2026
Long-Term Clinical Outcomes of nDSAEK and Machine Learning-Based Prediction of Graft Survival in Corneal Endothelial Decompensation.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To evaluate long-term outcomes of non-Descemet stripping automated endothelial keratoplasty (nDSAEK) in low-vision patients with corneal endothelial decompensation (CED), and to develop a machine-learning framework for predicting graft failure. Methods: This retrospective study included 114 eyes (Fuchs' and non-Fuchs' etiologies) treated with nDSAEK. Best-corrected visual acuity (BCVA), endothelial cell density (ECD), and complications were assessed over a long-term follow-up. Linear mixed-effects models (LMM) analyzed ECD kinetics. An XGBoost model using 10 clinical features was constructed to predict graft failure, interpreted via SHapley Additive exPlanations (SHAP) analysis. Results were compared against established endothelial keratoplasty benchmarks. Results: The median follow-up was 41.50 months (IQR: 25.65-55.75 months). Mean BCVA improved significantly from 1.80 logMAR baseline to 1.20 logMAR at 6 months, remaining stable thereafter. At 3 years, mean ECD was 1724 ± 279 cells/mm Conclusion: nDSAEK offers stable long-term visual and anatomical outcomes for CED. The integration of AI frameworks offers an exploratory framework for individualized prognostic screening, though further external validation is required before direct clinical integration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.